Research ArticleArticle
Safety, Tolerability, and Clinical Outcomes after Intraarticular Injection of a Recombinant Adeno-associated Vector Containing a Tumor Necrosis Factor Antagonist Gene: Results of a Phase 1/2 Study
Philip J. Mease, Nathan Wei, Edward J. Fudman, Alan J. Kivitz, Joy Schechtman, Robert G. Trapp, Kathryn F. Hobbs, Maria Greenwald, Antony Hou, Stephen A. Bookbinder, Galen E. Graham, Craig W. Wiesenhutter, Larry Willis, Eric M. Ruderman, Joseph Z. Forstot, Michael J. Maricic, Kathryn H. Dao, Charles H. Pritchard, Darrell N. Fiske, Francis X. Burch, H. Malin Prupas, Pervin Anklesaria and Alison E. Heald
The Journal of Rheumatology December 2009, jrheum.090817; DOI: https://doi.org/10.3899/jrheum.090817
Philip J. Mease
Nathan Wei
Edward J. Fudman
Alan J. Kivitz
Joy Schechtman
Robert G. Trapp
Kathryn F. Hobbs
Maria Greenwald
Antony Hou
Stephen A. Bookbinder
Galen E. Graham
Craig W. Wiesenhutter
Larry Willis
Eric M. Ruderman
Joseph Z. Forstot
Michael J. Maricic
Kathryn H. Dao
Charles H. Pritchard
Darrell N. Fiske
Francis X. Burch
H. Malin Prupas
Pervin Anklesaria
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Safety, Tolerability, and Clinical Outcomes after Intraarticular Injection of a Recombinant Adeno-associated Vector Containing a Tumor Necrosis Factor Antagonist Gene: Results of a Phase 1/2 Study
Philip J. Mease, Nathan Wei, Edward J. Fudman, Alan J. Kivitz, Joy Schechtman, Robert G. Trapp, Kathryn F. Hobbs, Maria Greenwald, Antony Hou, Stephen A. Bookbinder, Galen E. Graham, Craig W. Wiesenhutter, Larry Willis, Eric M. Ruderman, Joseph Z. Forstot, Michael J. Maricic, Kathryn H. Dao, Charles H. Pritchard, Darrell N. Fiske, Francis X. Burch, H. Malin Prupas, Pervin Anklesaria, Alison E. Heald
The Journal of Rheumatology Dec 2009, jrheum.090817; DOI: 10.3899/jrheum.090817
Safety, Tolerability, and Clinical Outcomes after Intraarticular Injection of a Recombinant Adeno-associated Vector Containing a Tumor Necrosis Factor Antagonist Gene: Results of a Phase 1/2 Study
Philip J. Mease, Nathan Wei, Edward J. Fudman, Alan J. Kivitz, Joy Schechtman, Robert G. Trapp, Kathryn F. Hobbs, Maria Greenwald, Antony Hou, Stephen A. Bookbinder, Galen E. Graham, Craig W. Wiesenhutter, Larry Willis, Eric M. Ruderman, Joseph Z. Forstot, Michael J. Maricic, Kathryn H. Dao, Charles H. Pritchard, Darrell N. Fiske, Francis X. Burch, H. Malin Prupas, Pervin Anklesaria, Alison E. Heald
The Journal of Rheumatology Dec 2009, jrheum.090817; DOI: 10.3899/jrheum.090817